Evidence for differences between the receptors present in the guinea pig ileum and those in the mouse vas deferens has come from Kosterlitz's laboratory (8, 9) . This group has also published studies on competition between opiate alkaloids and opioid peptides that point toward the existence of at least two kinds of receptors in rat brain (9). The latter results have recently been confirmed in our laboratory (10) and by others (11).
are more effective (7 and 30 timesg respectively) for the protection of 3H-labeled [D-Ala2,D-Leu enkephalin binding. These results provide strong evidence for the existence of two classes of opiate receptor in rat brain. The existence of multiple types of opiate receptors has been postulated on the basis of the large variety of pharmacological responses elicited by opiates as well as by endogenous opioid peptides. This hypothesis has been under increasingly active investigation since the biochemical demonstration of stereospecific opiate binding sites (1) (2) (3) and the discovery of the endogenous opioid peptides (4, 5) .
Pharmacological evidence suggesting multiple receptors was obtained in Martin' s laboratory in studies using chronic spinal dogs (6, 7) . Three types of opiate receptor were postulated and were named for their prototype ligands: Au for morphine, K for ethylketocyclazocine, and a for SKF 10,047. Evidence for differences between the receptors present in the guinea pig ileum and those in the mouse vas deferens has come from Kosterlitz's laboratory (8, 9) . This group has also published studies on competition between opiate alkaloids and opioid peptides that point toward the existence of at least two kinds of receptors in rat brain (9) . The latter results have recently been confirmed in our laboratory (10) and by others (11) .
These receptors were named ,u and 6 by Kosterlitz. Thequ receptor binds morphine and other opiate agonists and antagonists with much higher affinity than peptides and appears to resemble the , receptor of Martin. The 6 receptor binds enkephalins and their analogues with higher affinity than opiates.
The potent opiate etorphine, the peptide f3-endorphin, and analogues of enkephalin that lack a free carboxyl group, such as enkephalinamide, appear to bind with similar affinities to the two putative classes of receptors.
However, it is possible to explain the competition data obtained in rat brain homogenate in terms of a single receptor by suggesting that enkephalins and opiates bind to different functional groups on the receptor or bind via different types of chemical bonds. It is therefore highly desirable to utilize other approaches that may permit distinction between these two possibilities. The present report describes such an approach, the results of which support the hypothesis of two classes of receptors and are, in our view, difficult to explain in alternative ways.
We have reported that alkylation of SH groups by N-ethylmaleimide (MalNEt) irreversibly inactivates opiate receptor binding (12, 13 Methods. After removal of the cerebellum, brains of male Sprague-Dawley rats were homogenized in 10 vol of 50 mM Tris, pH 7.4/1 mM EDTA (subsequently termed "standard buffer") by using a Brinkmann Polytron at a setting of 6 for 20 sec. The homogenate was centrifuged at 20,000 X g for 20 min, and the sediment was resuspended in 6 vol of 0.32 M sucrose and stored at -20°C for [1] [2] [3] [4] [5] [6] days. The crude particulate fraction was hypotonically lysed by 1:10 dilution into standard buffer. For kinetic studies, suitable aliquots of the preparation were preincubated with 0.5 mM MalNEt at 37°C for 30 min. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
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Biochemistry: Smith and Simon on 2-ml samples as described below for the protection studies.
For protection studies, suitable aliquots of the preparation were simultaneously preincubated at 370C for 10 min with various concentrations of protecting ligand (morphine sulfate,
,Leu]enkephalin). MalNEt was then added to a final concentration of 0.5 mM and preincubation was continued at 370C for 20 min. Samples with morphine were protected from light throughout the 30-min total preincubation time. Preincubation was terminated by addition of reduced glutathione to a final concentration of 5 mM, followed by cooling at 00C for 10 min. Protecting ligands, glutathione, and MalNEt were removed from all samples by three 15-min centrifugations at 20,000 X g. The two washings were done in three times the original volume of standard buffer. The first washing included a 5-min incubation at 370C to allow protecting ligands to dissociate from receptor sites.
After 10 min, filtered, washed, dried and assayed for radioactivity in a toluene scintillation cocktail as described (1). We also find good correlation of protective efficacy with binding affinity for the [ (16) . Thus, the ,u receptor and the a receptor may indeed be separate, distinguishable entities, but the differences between them that result in differential ligand affinities appear to be quite subtle. This may be the major reason why distinguishing them has proved difficult. 
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